BELIEVE, GLP-1/GIP Agonists, and CATALYST Results at ADA 2025

In this episode of Diabetes Dialogue, cohosts Diana Isaacs, PharmD, an endocrine clinical pharmacist, director of Education and Training in Diabetes Technology, and co-director of Endocrine Disorders in Pregnancy at the Cleveland Clinic, and Natalie Bellini, DNP, program director of Diabetes Technology at University Hospitals Diabetes and Metabolic Care Center, continue their recap of ADA’s 2025 Scientific Sessions, spotlighting 3 more of the top clinical trials focused on obesity and type 2 diabetes.00:00:00 Intro00:00:31 BELIEVE Trial00:08:11 Phase 2 Maritide Trial00:17:12 CATALYST-2